Keywords: ortho, cleared, launch, axert, usa, ortho-mcneil, pharmaceuticals

Ortho cleared to launch Axert in USA

Article | 05 May 2003

Ortho-McNeil Pharmaceuticals has been given the go-ahead to re-launchthe antimigraine drug Axert (almotriptan malate), licensed from Spain's Almirall, in the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Almirall

Go to company listing

Related Drugs

Almotriptan Malate

Axert

Go to drug listing